Aerovate Therapeutics (NASDAQ:AVTE) just reported results for the fourth quarter of 2023.
- Aerovate Therapeutics reported earnings per share of -74 cents. This was below the analyst estimate for EPS of -71 cents.
- The company did not report any revenue for the quarter.